QIAGEN Files Lawsuit Against bioMérieux to Protect Key Innovations in TB Detection Technology

QIAGEN Files Lawsuit Against bioMérieux to Protect Key Innovations in TB Detection Technology

QIAGEN Files Lawsuit Against bioMérieux to Protect Key Innovations in TB Detection Technology (IN BRIEF) QIAGEN has filed a lawsuit against bioMérieux in the German Unified Patent Court to protect its QuantiFERON technology, specifically its European Patent EP 2 276 883 B2, which covers innovations in QuantiFERON-TB Gold Plus used for TB detection. This legal action highlights QIAGEN’s commitment to safeguarding its intellectual property after s…

Since its creation, Dreyfus has been a leader in the management of intellectual property rights (IPR) at the European level. Faced with the rise in world trade and the growing problems associated with counterfeiting, the company offers invaluable support to organisations of all sizes to protect and value their intangible assets.This article highlights recent trends in the application of IPRs in the European Union (EU), while relying on major cas…

Qiagen filed a complaint against the Lyon group for patent infringement. The French group will detail its 2024 accounts on Friday, March 7.